These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Inhibition of dipeptidyl peptidase-IV (DPP-IV) by atorvastatin. Taldone T; Zito SW; Talele TT Bioorg Med Chem Lett; 2008 Jan; 18(2):479-84. PubMed ID: 18068977 [TBL] [Abstract][Full Text] [Related]
7. Xanthine mimetics as potent dipeptidyl peptidase IV inhibitors. Kurukulasuriya R; Rohde JJ; Szczepankiewicz BG; Basha F; Lai C; Jae HS; Winn M; Stewart KD; Longenecker KL; Lubben TW; Ballaron SJ; Sham HL; von Geldern TW Bioorg Med Chem Lett; 2006 Dec; 16(24):6226-30. PubMed ID: 17010607 [TBL] [Abstract][Full Text] [Related]
8. Discovery, SAR, and X-ray structure of novel biaryl-based dipeptidyl peptidase IV inhibitors. Qiao L; Baumann CA; Crysler CS; Ninan NS; Abad MC; Spurlino JC; Desjarlais RL; Kervinen J; Neeper MP; Bayoumy SS; Williams R; Deckman IC; Dasgupta M; Reed RL; Huebert ND; Tomczuk BE; Moriarty KJ Bioorg Med Chem Lett; 2006 Jan; 16(1):123-8. PubMed ID: 16236500 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity relationships of potent 4-fluoro-2-cyanopyrrolidine dipeptidyl peptidase IV inhibitors. Fukushima H; Hiratate A; Takahashi M; Mikami A; Saito-Hori M; Munetomo E; Kitano K; Chonan S; Saito H; Suzuki A; Takaoka Y; Yamamoto K Bioorg Med Chem; 2008 Apr; 16(7):4093-106. PubMed ID: 18243000 [TBL] [Abstract][Full Text] [Related]
10. 4-arylcyclohexylalanine analogs as potent, selective, and orally active inhibitors of dipeptidyl peptidase IV. Kaelin DE; Smenton AL; Eiermann GJ; He H; Leiting B; Lyons KA; Patel RA; Patel SB; Petrov A; Scapin G; Wu JK; Thornberry NA; Weber AE; Duffy JL Bioorg Med Chem Lett; 2007 Nov; 17(21):5806-11. PubMed ID: 17851076 [TBL] [Abstract][Full Text] [Related]
11. In silico fragment-based discovery of DPP-IV S1 pocket binders. Rummey C; Nordhoff S; Thiemann M; Metz G Bioorg Med Chem Lett; 2006 Mar; 16(5):1405-9. PubMed ID: 16321524 [TBL] [Abstract][Full Text] [Related]
12. 1,3-disubstituted 4-aminopiperidines as useful tools in the optimization of the 2-aminobenzo[a]quinolizine dipeptidyl peptidase IV inhibitors. Lübbers T; Böhringer M; Gobbi L; Hennig M; Hunziker D; Kuhn B; Löffler B; Mattei P; Narquizian R; Peters JU; Ruff Y; Wessel HP; Wyss P Bioorg Med Chem Lett; 2007 Jun; 17(11):2966-70. PubMed ID: 17418568 [TBL] [Abstract][Full Text] [Related]
13. Discovery of beta-homophenylalanine based pyrrolidin-2-ylmethyl amides and sulfonamides as highly potent and selective inhibitors of dipeptidyl peptidase IV. Nordhoff S; Cerezo-Gálvez S; Deppe H; Hill O; López-Canet M; Rummey C; Thiemann M; Matassa VG; Edwards PJ; Feurer A Bioorg Med Chem Lett; 2009 Aug; 19(15):4201-3. PubMed ID: 19515557 [TBL] [Abstract][Full Text] [Related]
14. Triazolopiperazine-amides as dipeptidyl peptidase IV inhibitors: close analogs of JANUVIA (sitagliptin phosphate). Kim D; Kowalchick JE; Edmondson SD; Mastracchio A; Xu J; Eiermann GJ; Leiting B; Wu JK; Pryor KD; Patel RA; He H; Lyons KA; Thornberry NA; Weber AE Bioorg Med Chem Lett; 2007 Jun; 17(12):3373-7. PubMed ID: 17434732 [TBL] [Abstract][Full Text] [Related]
15. (3R)-4-[(3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one, a selective dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. Biftu T; Feng D; Qian X; Liang GB; Kieczykowski G; Eiermann G; He H; Leiting B; Lyons K; Petrov A; Sinha-Roy R; Zhang B; Scapin G; Patel S; Gao YD; Singh S; Wu J; Zhang X; Thornberry NA; Weber AE Bioorg Med Chem Lett; 2007 Jan; 17(1):49-52. PubMed ID: 17055272 [TBL] [Abstract][Full Text] [Related]
16. Crystal structures of DPP-IV (CD26) from rat kidney exhibit flexible accommodation of peptidase-selective inhibitors. Longenecker KL; Stewart KD; Madar DJ; Jakob CG; Fry EH; Wilk S; Lin CW; Ballaron SJ; Stashko MA; Lubben TH; Yong H; Pireh D; Pei Z; Basha F; Wiedeman PE; von Geldern TW; Trevillyan JM; Stoll VS Biochemistry; 2006 Jun; 45(24):7474-82. PubMed ID: 16768443 [TBL] [Abstract][Full Text] [Related]
17. Substituted pyrrolidine-2,4-dicarboxylic acid amides as potent dipeptidyl peptidase IV inhibitors. Tsai TY; Coumar MS; Hsu T; Hsieh HP; Chien CH; Chen CT; Chang CN; Lo YK; Wu SH; Huang CY; Huang YW; Wang MH; Wu HY; Lee HJ; Chen X; Chao YS; Jiaang WT Bioorg Med Chem Lett; 2006 Jun; 16(12):3268-72. PubMed ID: 16581245 [TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of new potent dipeptidyl peptidase IV inhibitors with enhanced ex vivo duration. Kondo T; Nekado T; Sugimoto I; Ochi K; Takai S; Kinoshita A; Tajima Y; Yamamoto S; Kawabata K; Nakai H; Toda M Bioorg Med Chem; 2007 Apr; 15(7):2631-50. PubMed ID: 17293118 [TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of potent amido- and benzyl-substituted cis-3-amino-4-(2-cyanopyrrolidide)pyrrolidinyl DPP-IV inhibitors. Corbett JW; Dirico K; Song W; Boscoe BP; Doran SD; Boyer D; Qiu X; Ammirati M; Vanvolkenburg MA; McPherson RK; Parker JC; Cox ED Bioorg Med Chem Lett; 2007 Dec; 17(24):6707-13. PubMed ID: 17977724 [TBL] [Abstract][Full Text] [Related]
20. First synthesis and determination of the absolute configuration of sulphostin, a novel inhibitor of dipeptidyl peptidase IV. Abe M; Akiyama T; Nakamura H; Kojima F; Harada S; Muraoka Y J Nat Prod; 2004 Jun; 67(6):999-1004. PubMed ID: 15217282 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]